Urantiis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
About Urantiis Pharmaceuticals
Urantiis Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2022 (Two years and eight months 3 days old ). Its registered office is in Chittoor, Andhra Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Vanguru Reddy and Rahamthulla Syed serve as directors at the Company.
Company Details
-
Location
Chittoor, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290AP2022PTC121896
-
Company No.
121896
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jun 2022
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Urantiis Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahamthulla Syed
|
Director | 06-Jun-2022 | Current |
|
Vanguru Reddy
|
Director | 06-Jun-2022 | Current |
Financial Performance of Urantiis Pharmaceuticals.
Enhance accessibility to Urantiis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Urantiis Pharmaceuticals?
Unlock access to Urantiis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pathgene Health Care Private LimitedRahamthulla Syed is a mutual person
-
Tirupati Electronics Manufacturing Cluster LimitedRahamthulla Syed is a mutual person
-
Toxgene Ar Biolabs Private Limited
Rahamthulla Syed is a mutual person
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2024 | Bank Of India | ₹6.00 M | Open |
How Many Employees Work at Urantiis Pharmaceuticals?
Urantiis Pharmaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urantiis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urantiis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.